Can Systemic Diseases Co-induce ( Not Just Exacerbate) Periodontitis? A Hypothetical “Two-hit” Model

Abstract

Get full access to this article

View all access options for this article.

References

Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G, et al. -2003-. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107:1579–1585.

Brandt KD, Mazzuca SA, Katz BP, Lane KA, Buckwalter KA, Yocum DE, et al. -2005-. Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial. Arthritis Rheum 52:2015–2025.

Brown DL, Desai KK, Vakili BA, Nouneh C, Lee HM, Golub LM -2004-. Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes -MIDAS- pilot trial. Arterioscler Thromb Vasc Biol 24:733–738.

Carney DE, Lutz CJ, Picone AL, Gatto LA, Ramamurthy NS, Golub LM, et al. -1999-. Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass. Circulation 100:400–406.

Cenci S, Toraldo G, Weitzmann MN, Roggia C, Gao Y, Qian WP, et al. -2003-. Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Natl Acad Sci USA 100:10405–10410.

Choi BK, Moon SY, Cha JH, Kim KW, Yoo YJ -2005-. Prostaglandin E-2- is a main mediator in receptor activator of nuclear factor-kappaB ligand-dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii. J Periodontol 76:813–820.

Craig RG, Yip JK, So MK, Socransky SS, Haffajee AD -2003-. Relationship of destructive periodontal disease to the acute-phase response. J Periodontol 74:1007–1016.

D’Aiuto F, Parkar M, Andreou G, Suvan J, Brett PM, Ready D, et al. -2004-. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 83:156–160.

Elliott J, Paulsen GA, Mallek JA, Mikuls TR, Weaver CA, Glickstein S, et al. -2003-. Treatment of early sero-positive rheumatoid arthritis: doxycycline with methotrexate versus methotrexate alone -abstract-. Arthritis Rheum 48-Suppl-:S1708.

10.

Gaspersic R, Stiblar-Martincic D, Osredkar J, Skaleric U -2003-. Influence of subcutaneous administration of recombinant TNF-alpha on ligature-induced periodontitis in rats. J Periodontal Res 38:198–203.

11.

Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T -1998-. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 12:12–26.

12.

Golub LM, Ramamurthy NS, Llavaneras A, Ryan ME, Lee HM, Liu Y, et al. -1999-. A chemically modified nonantimicrobial tetracycline -CMT-8- inhibits gingival matrix metalloproteinases, periodontal breakdown, and extra-oral bone loss in ovariectomized rats. Ann NY Acad Sci 878:290–310.

13.

Gough A, Sambrook P, Devlin J, Huissoon A, Njeh C, Robbins S, et al. -1998-. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis. J Rheumatol 25:1282–1289.

14.

Greenwald RA, Kirkwood K -1999-. Adult periodontitis as a model for rheumatoid arthritis -with emphasis on treatment strategies-. J Rheumatol 26:1650–1653.

15.

Greenwald RA, Moak SA, Ramamurthy NS, Golub LM -1992-. Tetracyclines suppress metalloproteinase activity in adjuvant arthritis and, in combination with flurbiprofen, ameliorate bone damage. J Rheumatol 19:927–938.

16.

Haynes DR -2004-. Bone lysis and inflammation. Inflamm Res 53:596–600.

17.

Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL -2000-. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15:2–12.

18.

Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, et al. -1992-. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88–91.

19.

Kasser UR, Gleissner C, Dehne F, Michel A, Willershausen-Zonnchen B, Bolten WW -1997-. Risk for periodontal disease in patients with longstanding rheumatoid arthritis. Arthritis Rheum 40:2248–2251.

20.

Kent LW, Rahemtulla F, Michalek SM -1999-. Interleukin -IL--1 and Porphyromonas gingivalis lipopolysaccharide stimulation of IL-6 production by fibroblasts derived from healthy or periodontally diseased human gingival tissue. J Periodontol 70:274–282.

21.

Kimble RB, Bain S, Pacifici R -1997-. The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res 12:935–941.

22.

Kitazawa R, Kimble RB, Vannice JL, Kung VT, Pacifici R -1994-. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest 94:2397–2406.

23.

Krall EA, Garcia RI, Dawson-Hughes B -1996-. Increased risk of tooth loss is related to bone loss at the whole body, hip, and spine. Calcif Tissue Int 59:433–437.

24.

Lavnikova N, Laskin DL -1995-. Unique patterns of regulation of nitric oxide production in fibroblasts. J Leukoc Biol 58:451–458.

25.

Lotz M, Blanco FJ, von Kempis J, Dudler J, Maier R, Villiger PM, et al. -1995-. Cytokine regulation of chondrocyte functions. J Rheumatol 43-Suppl-:104–108.

26.

McGee JM, Tucci MA, Edmundson TP, Serio CL, Johnson RB -1998-. The relationship between concentrations of proinflammatory cytokines within gingiva and the adjacent sulcular depth. J Periodontol 69:865–871.

27.

Miranda LA, Fischer RG, Sztajnbok FR, Figueredo CM, Gustafsson A -2003-. Periodontal conditions in patients with juvenile idiopathic arthritis. J Clin Periodontol 30:969–974.

28.

Miranda LA, Fischer RG, Sztajnbok FR, Johansson A, Figueredo CM, Gustafsson A -2005-. Increased interleukin-18 in patients with juvenile idiopathic arthritis and early attachment loss. J Periodontol 76:75–82.

29.

Nanes MS -2003-. Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 321:1–15.

30.

Pacifici R -1996-. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:1043–1051.

31.

Patrick DA, Moore FA, Moore EE, Barnett CC Jr, Silliman CC -1996-. Neutrophil priming and activation in the pathogenesis of postinjury multiple organ failure. New Horiz 4:194–210.

32.

Payne JB, Reinhardt RA -1998-. Potential application of low-dose doxycycline to treat periodontitis in post-menopausal women. Adv Dent Res 12:166–169.

33.

Payne JB, Reinhardt RA, Nummikoski PV, Patil KD -1999-. Longitudinal alveolar bone loss in postmenopausal osteoporotic/osteopenic women. Osteoporos Int 10:34–40.

34.

Ramamurthy NS, Rifkin BR, Greenwald RA, Xu JW, Liu Y, Turner G, et al. -2002-. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines. J Periodontol 73:726–734.

35.

Ramamurthy NS, Greenwald RA, Celiker MY, Shi EY -2005-. Experimental arthritis in rats induces biomarkers of periodontitis which are ameliorated by gene therapy with tissue inhibitor of matrix metalloproteinases. J Periodontol 76:229–233.

36.

Ridker PM, Rifai N, Rose L, Buring JE, Cook NR -2002-. Comparison of C-reactive protein and low density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557–1565.

37.

Roggia C, Gao Y, Cenci S, Weitzmann MN, Toraldo G, Isaia G, et al. -2001-. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA 98:13960–13965.

38.

Ryan ME, Carnu O, Kamer A -2003-. The influence of diabetes on the periodontal tissues. J Am Dent Assoc 134:345–405.-AQ-

39.

Soory M -2002-. Hormone mediation of immune responses in the progression of diabetes, rheumatoid arthritis and periodontal diseases. Curr Drug Targets Immune Endocr Metabol Discord 2:13–25.

40.

Steinberg J, Halter J, Schiller H, Gatto L, Nieman G -2005a-. The development of acute respiratory distress syndrome after gut ischemia/reperfusion injury followed by fecal peritonitis in pigs: a clinically relevant model. Shock 23:129–137.

41.

Steinberg J, Halter J, Schiller H, Gatto L, Carney D, Lee HM, et al. -2005b-. Chemically modified tetracycline prevents the development of septic shock and acute respiratory distress syndrome in a clinically applicable porcine model. Shock 24:348–356.

42.

Uitto VJ, Airola K, Vaalamo M, Johannson N, Putnins EE, Firth JD, et al. -1998-. Collagenase-3 -matrix metalloproteinase-13- expression is induced in oral mucosal epithelium during chronic inflammation. Am J Pathol 152:1489–1499.

43.

Vreugdenhil G, Lowenberg B, van Eijk HG, Swaak AJ -1990-. Anaemia of chronic disease in rheumatoid arthritis. Raised serum interleukin-6 -IL-6- levels and effects of IL-6 and anti-IL-6 on in vitro erythropoiesis. Rheumatol Int 10:127–130.

44.

Yilmaz M, Kendirli SG, Altintas D, Bingol G, Antmen B -2001-. Cytokine levels in serum of patients with juvenile rheumatoid arthritis. Clin Rheumatol 20:30–35.